[toc]

- [Summaries](/page/susceptibility-data/#summaries)
  - [Table 1: Virus Variants and Spike Mutations vs Monoclonal Antibodies](/page/susceptibility-data/#table.1.virus.variants.and.spike.mutations.vs.monoclonal.antibodies)
  - [Table 2: Virus Variants and Spike Mutations vs Convalescent Plasma and Plasma from Vaccinated Persons](/page/susceptibility-data/#table.2.virus.variants.and.spike.mutations.vs.convalescent.plasma.and.plasma.from.vaccinated.persons)
  - [Figure: Virus Variants and Spike Mutations vs Convalescent Plasma and Plasma from Vaccinated Persons](/page/susceptibility-data/#figure.virus.variants.and.spike.mutations.vs.convalescent.plasma.and.plasma.from.vaccinated.persons)
- Raw data
  - [Spike variants and mutation combinations / monoclonal antibodies neutralization](https://hivdb.github.io/covid-drdb-reports/resistance-dt.html#spike-variants-and-mutation-combinations-mab-neutralization)
  - [Spike variants and mutation combinations / plasma neutralization](https://hivdb.github.io/covid-drdb-reports/resistance-dt.html#spike-variants-and-mutation-combinations-plasma-neutralization)
  - [Spike mutations _in vitro_ selection](https://hivdb.github.io/covid-drdb-reports/resistance-dt.html#spike-mutation-invitro-selection-cp-and-mab)
- **Individual study details**
  - [Table S1: Neutralizing Sensitivity of Variants of Concern to Convalescent Plasma and Plasma from Vaccinated Persons](/page/susceptibility-data/plasma-variant/)
  - [Table S2: Neutralizing Sensitivity of Variants of Concern to Monoclonal Antibodies](/page/susceptibility-data/mab-variant/)
  - [Table S3: Neutralizing Sensitivity of Spike Mutations to Convalescent Plasma and Plasma from Vaccinated Persons](/page/susceptibility-data/plasma-mutations/)
  - **Table S4: Neutralizing Sensitivity of Spike Mutations to Monoclonal Antibodies**

[/toc]

### Table S4: Neutralizing Sensitivity of Spike Mutations to Monoclonal Antibodies

[table]
table_mab_muts
[/table]
